Last reviewed · How we verify
Guaneran (tiamiprine)
Guaneran (generic name: tiamiprine) is a tiamiprine drug. It is currently in unknown development.
Guaneran is thought to work by interacting with specific biological molecules to modulate their activity.
Guaneran is a small molecule compound with the synonyms AZATHIOPRINE RELATED COMPOUND G, BW 57-323, and others. Its exact mechanism and indications are not specified in the provided information.
At a glance
| Generic name | tiamiprine |
|---|---|
| Drug class | tiamiprine |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like a orchestra, and each cell has its own set of instructions to follow. Guaneran is like a conductor that helps the cells follow the right instructions, but how it does this is not yet fully understood. It's like a fine-tuning mechanism that helps the cells work together in harmony.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Guaneran CI brief — competitive landscape report
- Guaneran updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Guaneran
What is Guaneran?
How does Guaneran work?
What is the generic name of Guaneran?
What drug class is Guaneran in?
What development phase is Guaneran in?
Related
- Drug class: All tiamiprine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing